Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Assets Average: 2011-2025

Historic Assets Average for Catalyst Pharmaceuticals (CPRX) over the last 12 years, with Sep 2025 value amounting to $1.0 billion.

  • Catalyst Pharmaceuticals' Assets Average rose 36.87% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 36.87%. This contributed to the annual value of $660.8 million for FY2024, which is 56.26% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Assets Average stood at $1.0 billion for Q3 2025, which was up 7.59% from $940.4 million recorded in Q2 2025.
  • Catalyst Pharmaceuticals' Assets Average's 5-year high stood at $1.0 billion during Q3 2025, with a 5-year trough of $194.8 million in Q1 2021.
  • Moreover, its 3-year median value for Assets Average was $676.5 million (2024), whereas its average is $664.1 million.
  • Data for Catalyst Pharmaceuticals' Assets Average shows a peak YoY surged of 83.79% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' Assets Average stood at $230.5 million in 2021, then surged by 53.73% to $354.4 million in 2022, then climbed by 24.63% to $441.7 million in 2023, then surged by 83.79% to $811.7 million in 2024, then surged by 36.87% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q3 2025, $940.4 million for Q2 2025, and $880.1 million during Q1 2025.